← All candidates
No insider filings on record.
3 filings on record.
VRXAWVeraxa Biotech Holding AG
NasdaqCM
$0.1400
-0.71% · Jul 10
No insider filings on record.
Veraxa Biotech Holding AG hasn't reported Form 4 activity yet.
Price · 1Y · dailyNo open-market activity in range
▸ hover a marker for the filing · drag to zoom · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Short % float
Pro
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
3 filingsnewest first
The record
newest first
No insider transactions on file for VRXAW yet.
Context
Coverage
VERAXA Biotech Designates Raju Willener as CFOExec Edge · 1w agoThe Cancer Therapy Strategy VERAXA Is Betting the Company OnExec Edge · 07-06VERAXA Biotech Stock in Focus as Lead Cancer Program Reaches Development MilestoneExec Edge · 07-02VERAXA Biotech Expands R&D Hub in Heidelberg as Programs Advance Towards Clinical DevelopmentExec Edge · 06-24
The file stays open
3 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice